Alpa Laboratories Limited (NSE:ALPA)
India · Delayed Price · Currency is INR 51.63
-5.05 (-8.91%)
At close: Mar 27, 2026
Alpa Laboratories Market Cap
Alpa Laboratories has a market cap or net worth of 1.09 billion as of March 27, 2026. Its market cap has decreased by -52.48% in one year.
Market Cap
1.09B
Enterprise Value
-303.49M
Revenue
1.14B
Ranking
n/a
PE Ratio
9.36
Stock Price
51.63
Market Cap Chart
Since August 7, 2007, Alpa Laboratories's market cap has decreased from 1.15B to 1.09B, a decrease of -5.78%. That is a compound annual growth rate of -0.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 1.09B | -33.54% |
| Dec 31, 2025 | 1.63B | -34.42% |
| Dec 31, 2024 | 2.49B | 14.68% |
| Dec 29, 2023 | 2.17B | 63.97% |
| Dec 30, 2022 | 1.33B | -20.65% |
| Dec 31, 2021 | 1.67B | 119.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Drugs | 11.76B |
| Sakar Healthcare | 11.53B |
| Sigachi Industries | 6.96B |
| Valiant Laboratories | 2.91B |
| Bafna Pharmaceuticals | 2.70B |
| Nectar Lifesciences | 1.90B |
| Brooks Laboratories | 1.27B |
| Par Drugs and Chemicals | 991.02M |